TrademarkDir
NUPULSE
LIVE

Serial Number

88723769

Owner

NUPULSECV, INC.

Attorney

Susan Piascik Christoff

First Use Date

Jul 13, 2022

Filing Date

Dec 11, 2019

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

NUPULSE Trademark

Serial Number: 88723769 • Registration: 7164413

NUPULSE is a trademark filed by NUPULSECV, INC. on December 11, 2019. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

NUPULSECV, INC. (2 trademarks)

RALEIGH, NC 27607

Entity Type: 03

Trademark Details

Filing Date

December 11, 2019

Registration Date

September 12, 2023

First Use Anywhere

July 13, 2022

First Use in Commerce

July 13, 2022

Published for Opposition

May 12, 2020

Goods & Services

Medical apparatus for the treatment of heart failure; Medical apparatus, namely, an intravascular ventricular assist system comprised of a blood pump, skin interface device, arterial interface device, subcutaneous ECG leads, internal drive line, and drive unit for use in the treatment of advanced heart failure; Medical devices for supporting cardiac function in humans, namely, blood pumps for use in the cardiovascular system to the heart, catheters, intravascular access devices and external power sources specially adapted therefor, sold as a unit

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 25, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 25, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 25, 2025 REAP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 12, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 12, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Aug 10, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Aug 9, 2023 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jul 10, 2023 SUPC
USE AMENDMENT FILED
Jul 6, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
Jul 6, 2023 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 14, 2023 EXRA
SOU EXTENSION 5 GRANTED
Jan 13, 2023 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 12, 2023 AITU
SOU EXTENSION 5 FILED
Dec 28, 2022 EXT5
SOU TEAS EXTENSION RECEIVED
Dec 28, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 5, 2022 EXRA
SOU EXTENSION 4 GRANTED
Jul 1, 2022 EX4G
SOU EXTENSION 4 FILED
Jul 1, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Jul 1, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 7, 2022 EXRA
SOU EXTENSION 3 GRANTED
Jan 5, 2022 EX3G
SOU EXTENSION 3 FILED
Jan 5, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 5, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 8, 2021 EXRA
SOU EXTENSION 2 GRANTED
Jul 6, 2021 EX2G
SOU EXTENSION 2 FILED
Jul 6, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 6, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 9, 2021 EXRA
SOU EXTENSION 1 GRANTED
Jan 7, 2021 EX1G
SOU EXTENSION 1 FILED
Jan 7, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 7, 2021 EEXT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 6, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 6, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 6, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 6, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 6, 2021 COAR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 7, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 12, 2020 NPUB
PUBLISHED FOR OPPOSITION
May 12, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 22, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 25, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 24, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 23, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 23, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 14, 2020 GNRN
NON-FINAL ACTION E-MAILED
Mar 14, 2020 GNRT
NON-FINAL ACTION WRITTEN
Mar 14, 2020 CNRT
ASSIGNED TO EXAMINER
Mar 11, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 16, 2019 NWOS
NEW APPLICATION ENTERED
Dec 14, 2019 NWAP

Related Trademarks

More from this Owner

NUPULSECV

NUPULSECV

NUPULSECV

NUPULSECV